¼¼°èÀÇ ¹ÙÀÌ¿ÀĨ ½ÃÀå º¸°í¼­(2025³â)
Biochips Global Market Report 2025
»óǰÄÚµå : 1702936
¸®¼­Ä¡»ç : The Business Research Company
¹ßÇàÀÏ : On Demand Report
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 200 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,490 £Ü 6,371,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,490 £Ü 9,209,000
PDF (Site License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷ÀåÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,490 £Ü 12,048,000
PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
¤± º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼Û±âÀÏÀº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¹ÙÀÌ¿ÀĨ ½ÃÀå ±Ô¸ð´Â ÇâÈÄ ¸î ³â µ¿¾È ºü¸£°Ô ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2029³â±îÁö 16.3%ÀÇ ¿¬Æò±Õ ¼ºÀå·ü(CAGR)·Î 269¾ï 4,000¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ¿¹Ãø ±â°£ µ¿¾È ¼ºÀå ±âȸ´Â ÇöÀå Áø´ÜÀÇ Ã¤Åà Áõ°¡, ÀǾàǰ °³¹ß¿¡¼­ÀÇ Àû¿ë È®´ë, °³ÀÎ ¸ÂÃãÇü ÀÇ·á¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡, ¹Ì¼¼ À¯Ã¼ ±â¼úÀÇ ¹ßÀü, R&D ÅõÀÚ È®´ë, »ý¸í°øÇÐ ±â¾÷°ú ÇаèÀÇ Çù·Â È®´ë, ³ó¾÷ »ý¸í°øÇÐÀÇ »õ·Î¿î ±âȸ ÃâÇö µîÀ¸·Î ÀÎÇØ ¹ß»ýÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.ÀÇ »õ·Î¿î ±âȸÀÇ ÃâÇö µî¿¡ ±âÀÎÇÏ´Â °ÍÀ¸·Î º¸ÀÔ´Ï´Ù. ¿¹Ãø ±â°£ÀÇ ÁÖ¿ä µ¿ÇâÀ¸·Î´Â ¸¶ÀÌÅ©·ÎÇ÷çÀ̵ñ½º ±â¼úÀÇ ¹ßÀü, ¾×ü »ý°Ë ÀÀ¿ëÀ» À§ÇÑ ¹ÙÀÌ¿ÀĨ °³¹ßÀÇ Á߿伺, ¿©·¯ ºÐ¼®¹°ÀÇ µ¿½Ã °ËÃâÀ» À§ÇÑ ¸ÖƼÇ÷º½º ºÐ¼®¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡, µ¥ÀÌÅÍ ºÐ¼®À» À§ÇÑ ÀΰøÁö´ÉÀÇ ÅëÇÕ, »õ·Î¿î ¹ÙÀÌ¿ÀĨ Ç÷§ÆûÀÇ ÃâÇö µîÀÌ ÀÖ½À´Ï´Ù. »õ·Î¿î ¹ÙÀÌ¿ÀĨ Ç÷§ÆûÀÇ ÃâÇö µîÀ» µé ¼ö ÀÖ½À´Ï´Ù.

¹ÙÀÌ¿ÀĨ ½ÃÀåÀº °³ÀÎ ¸ÂÃãÇü ÀÇ·áÀÇ Ã¤ÅÃÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ¼ºÀåÀÌ ¿¹»óµÇ°í ÀÖ½À´Ï´Ù. °³ÀθÂÃãÀÇ·á´Â À¯ÀüÇÐ, »ýȰ½À°ü µî °³ÀÎÀÇ Æ¯¼º¿¡ µû¶ó Ä¡·á¸¦ ¸ÂÃãÈ­ÇÏ¿© È¿°ú¸¦ ÃÖÀûÈ­ÇÏ°í ºÎÀÛ¿ëÀ» ÃÖ¼ÒÈ­ÇÏ´Â °ÍÀ» ¸ñÇ¥·Î ÇÕ´Ï´Ù. ÀÌ·¯ÇÑ Ãß¼¼´Â º¸´Ù È¿°úÀûÀÎ Ä¡·á¸¦ Á¦°øÇÒ ¼ö ÀÖ´Â ¸ÂÃãÀÇ·áÀÇ °¡´É¼º, À¯ÀüüÇÐÀÇ ¹ßÀü, Áúº´ÀÇ º¹À⼺, ±ÔÁ¦ÀÇ µÞ¹Þħ¿¡ ÀÇÇØ ÃËÁøµÇ°í ÀÖ½À´Ï´Ù. ¹ÙÀÌ¿ÀĨÀº °³ÀÎÀÇ À¯ÀüÀÚ ÇÁ·ÎÆÄÀÏ¿¡ ±â¹ÝÇÑ Á¤È®ÇÏ°í ¸ÂÃã Ä¡·á °èȹÀ» °¡´ÉÇÏ°Ô ÇÔÀ¸·Î½á °³ÀÎ ¸ÂÃãÇü ÀÇ·á¿¡¼­ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, 2024³â 2¿ù FDA´Â Èñ±ÍÁúȯ¿¡ ´ëÇÑ 16°³ÀÇ »õ·Î¿î °³ÀθÂÃãÇü Ä¡·áÁ¦¸¦ ½ÂÀÎÇÏ¿© °³ÀθÂÃãÇü ÀÇ·á µµÀÔÀÇ ¸ð¸àÅÒ°ú ¹ÙÀÌ¿ÀĨ ½ÃÀå¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» °­Á¶Çϰí ÀÖ½À´Ï´Ù.

¹ÙÀÌ¿ÀĨ ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷µéÀº ½Å¾à °³¹ß ¹× ½ÃÀå °³Ã´ °úÁ¤À» Çõ½ÅÇϱâ À§ÇØ Àå±â ¿ÂĨ Ç÷§Æû°ú °°Àº ÷´Ü ±â¼ú °³¹ß¿¡ ÁýÁßÇϰí ÀÖ½À´Ï´Ù. Àå±â ¿ÂĨ Ç÷§ÆûÀº Àΰ£ Àå±âÀÇ »ý¸®Àû Ư¼º°ú ±â´ÉÀ» ¼Ò±Ô¸ð·Î ¸ð¹æÇϵµ·Ï ¼³°èµÈ ÷´Ü ¸¶ÀÌÅ©·ÎÇ÷çÀ̵ñ½º ÀåÄ¡ÀÔ´Ï´Ù. ¿¹¸¦ µé¾î, 2024³â 4¿ù º¸½ºÅÏ ¸¶ÀÌÅ©·ÎÆÐºê¸®ÄÉÀ̼Ç(BMF)Àº BMF ¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö(BMF Biotechnology Inc.)¸¦ ¼³¸³ÇÏ¿© ¹ÙÀÌ¿ÀĨ°ú ½ÃÇè°ü ³» ´ë±Ô¸ð Á¶Á÷ ¹è¾çÀ» À§ÇÑ Àå±â ¿ÂĨ Ç÷§ÆûÀ» Àü¹®À¸·Î Çϰí ÀÖ½À´Ï´Ù. ÀÌ ¹ßÀüÀº ÀÎü ¿Ü ½ÃÇè ¹× ¿¬±¸ Ç÷§ÆûÀ» Á¦°øÇÔÀ¸·Î½á ÀǾàǰ ¹× È­Àåǰ °³¹ßÀ» °¡¼ÓÈ­ÇÕ´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ½ÃÀå Æ¯Â¡

Á¦3Àå ½ÃÀå µ¿Çâ°ú Àü·«

Á¦4Àå ½ÃÀå - ±Ý¸®, ÀÎÇ÷¹À̼Ç, ÁöÁ¤ÇÐ, ½ÅÇü Äڷγª¹ÙÀÌ·¯½º, ±×¸®°í °æ±âȸº¹ÀÌ ½ÃÀå¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» Æ÷ÇÔÇÑ °Å½Ã°æÁ¦ ½Ã³ª¸®¿À

Á¦5Àå ¼¼°èÀÇ ¼ºÀå ºÐ¼®°ú Àü·« ºÐ¼® ÇÁ·¹ÀÓ¿öÅ©

Á¦6Àå ½ÃÀå ¼¼ºÐÈ­

Á¦7Àå Áö¿ªº°/±¹°¡º° ºÐ¼®

Á¦8Àå ¾Æ½Ã¾ÆÅÂÆò¾ç ½ÃÀå

Á¦9Àå Áß±¹ ½ÃÀå

Á¦10Àå Àεµ ½ÃÀå

Á¦11Àå ÀϺ» ½ÃÀå

Á¦12Àå È£ÁÖ ½ÃÀå

Á¦13Àå Àεµ³×½Ã¾Æ ½ÃÀå

Á¦14Àå Çѱ¹ ½ÃÀå

Á¦15Àå ¼­À¯·´ ½ÃÀå

Á¦16Àå ¿µ±¹ ½ÃÀå

Á¦17Àå µ¶ÀÏ ½ÃÀå

Á¦18Àå ÇÁ¶û½º ½ÃÀå

Á¦19Àå ÀÌÅ»¸®¾Æ ½ÃÀå

Á¦20Àå ½ºÆäÀÎ ½ÃÀå

Á¦21Àå µ¿À¯·´ ½ÃÀå

Á¦22Àå ·¯½Ã¾Æ ½ÃÀå

Á¦23Àå ºÏ¹Ì ½ÃÀå

Á¦24Àå ¹Ì±¹ ½ÃÀå

Á¦25Àå ij³ª´Ù ½ÃÀå

Á¦26Àå ³²¹Ì ½ÃÀå

Á¦27Àå ºê¶óÁú ½ÃÀå

Á¦28Àå Áßµ¿ ½ÃÀå

Á¦29Àå ¾ÆÇÁ¸®Ä« ½ÃÀå

Á¦30Àå °æÀï ±¸µµ¿Í ±â¾÷ °³¿ä

Á¦31Àå ±âŸ ÁÖ¿ä ±â¾÷ ¹× Çõ½Å ±â¾÷

Á¦32Àå ¼¼°è ½ÃÀå °æÀï º¥Ä¡¸¶Å·°ú ´ë½Ãº¸µå

Á¦33Àå ÁÖ¿ä ÀμöÇÕº´(M&A)

Á¦34Àå ÃÖ±Ù ½ÃÀå µ¿Çâ

Á¦35Àå ½ÃÀå ÀáÀç·ÂÀÌ ³ôÀº ±¹°¡, ºÎ¹®, Àü·«

Á¦36Àå ºÎ·Ï

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Biochips are compact devices containing an assortment of biological substances such as DNA, proteins, or cells, affixed onto a solid surface. They merge biological components with electronic systems for studying and manipulating biological data, finding extensive use in medical diagnostics, genetic sequencing, and other biotechnological domains.

The primary types of biochips include DNA chips (or DNA microarrays), protein chips, lab-on-chip systems, tissue arrays, and cell arrays. DNA chips allow the simultaneous analysis of numerous genes' expressions, leveraging technologies such as microarrays and microfluidics. These biochips find applications in drug discovery, agriculture, genomics, disease diagnostics, proteomics, and are utilized by diverse end users such as biotech firms, pharmaceutical companies, academic institutions, hospitals, and diagnostic centers.

The biochips market research report is one of a series of new reports from The Business Research Company that provides biochips market statistics, including biochips industry global market size, regional shares, competitors with a biochips market share, detailed biochips market segments, market trends and opportunities, and any further data you may need to thrive in the biochips industry. This biochips market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The biochips market size has grown rapidly in recent years. It will grow from $12.62 billion in 2024 to $14.72 billion in 2025 at a compound annual growth rate (CAGR) of 16.6%. The growth in the historic period can be attributed to increased demand for personalized medicine, high prevalence of chronic diseases, technological innovations, expanded applications in drug discovery, growth in investments in research and development, and supportive regulatory frameworks.

The biochips market size is expected to see rapid growth in the next few years. It will grow to $26.94 billion in 2029 at a compound annual growth rate (CAGR) of 16.3%. The growth in the forecast period can be attributed to increasing adoption in point-of-care diagnostics, expanding applications in drug development, rising demand for personalized medicine, advancements in microfluidics technology, growing investments in research and development, expanding collaborations between biotechnology companies and academic institutions, and emerging opportunities in agricultural biotechnology. Major trends in the forecast period include advancements in microfluidics technology, emphasis on developing biochips for liquid biopsy applications, rising demand for multiplexed assays for simultaneous detection of multiple analytes, integration of artificial intelligence for data analysis, and the emergence of novel biochip platforms.

The biochips market is poised for growth due to the increasing adoption of personalized medicines. Personalized medicine involves tailoring medical treatments based on individual characteristics such as genetics or lifestyle, aiming to optimize effectiveness and minimize adverse effects. This trend is fueled by the potential of personalized medicine to offer more effective treatments, advancements in genomics, the rising complexity of diseases, and regulatory backing. Biochips play a crucial role in personalized medicine by enabling precise and individualized treatment plans based on a person's genetic profile. For instance, in February 2024, the FDA approved 16 novel personalized therapies for rare diseases in 2023, highlighting the momentum in personalized medicine adoption and its impact on the biochips market.

Leading companies in the biochips market are focusing on developing cutting-edge technologies such as organ-on-a-chip platforms to transform drug discovery and development processes. Organ-on-a-chip platforms are sophisticated microfluidic devices designed to mimic the physiological characteristics and functions of human organs on a smaller scale. For example, in April 2024, Boston Micro Fabrication (BMF) launched BMF Biotechnology Inc., specializing in biochips or organ-on-a-chip platforms for cultivating large-scale tissues in vitro. This advancement accelerates drug and cosmetic development by providing a testing and research platform outside the human body.

In June 2023, Randox Laboratories acquired Cellix Limited to bolster its expertise in benchtop flow cytometry, aligning with its commitment to personalized medicine and improved preventive healthcare. This acquisition expands Randox's portfolio and makes flow cytometry technology more accessible to a wider range of researchers and healthcare professionals. Cellix Limited, based in Ireland, specializes in creating biochips for various applications in the life sciences.

Major companies operating in the biochips market are Thermo Fisher Scientific Inc., Roche Diagnostics International Ltd, Zoetis Inc., Agilent Technologies Inc., PerkinElmer Inc., Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Tecan Group Ltd., Cepheid Inc., Randox Laboratories Ltd., Takara Bio Inc., Oxford Nanopore Technologies plc, Luminex Corporation, Fluidigm Corporation, Micronit Microtechnologies B.V., Sphere Fluidics Limited, Sengenics, Arrayit Corporation, CustomArray Inc., Partek Incorporated, NanoCellect Biomedical Inc., Dolomite Microfluidics, Biocartis NV

North America was the largest region in the biochips market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biochips market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the biochips market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The biochips market consists of sales of lab-on-a-chip (LOC) devices, cellular microarrays, and protein microarrays. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Biochips Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on biochips market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for biochips ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The biochips market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Biochips Market Characteristics

3. Biochips Market Trends And Strategies

4. Biochips Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Biochips Growth Analysis And Strategic Analysis Framework

6. Biochips Market Segmentation

7. Biochips Market Regional And Country Analysis

8. Asia-Pacific Biochips Market

9. China Biochips Market

10. India Biochips Market

11. Japan Biochips Market

12. Australia Biochips Market

13. Indonesia Biochips Market

14. South Korea Biochips Market

15. Western Europe Biochips Market

16. UK Biochips Market

17. Germany Biochips Market

18. France Biochips Market

19. Italy Biochips Market

20. Spain Biochips Market

21. Eastern Europe Biochips Market

22. Russia Biochips Market

23. North America Biochips Market

24. USA Biochips Market

25. Canada Biochips Market

26. South America Biochips Market

27. Brazil Biochips Market

28. Middle East Biochips Market

29. Africa Biochips Market

30. Biochips Market Competitive Landscape And Company Profiles

31. Biochips Market Other Major And Innovative Companies

32. Global Biochips Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Biochips Market

34. Recent Developments In The Biochips Market

35. Biochips Market High Potential Countries, Segments and Strategies

36. Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â